Copyright
©The Author(s) 2017.
World J Clin Oncol. Aug 10, 2017; 8(4): 336-342
Published online Aug 10, 2017. doi: 10.5306/wjco.v8.i4.336
Published online Aug 10, 2017. doi: 10.5306/wjco.v8.i4.336
Mean | Criteria | Ethical Framework | |
Strongly disagree | 0.0 | ||
37.1 | Order of arrival should impact the priority given to a patient | First-come first-served | |
41.8 | A patient with fewer co-morbidities should be given priority over a patient who has more co-morbidities | Sickest first | |
44.3 | Younger patients should receive priority over older patients | Fair innings | |
47.3 | A patient with longer anticipated survival should be given priority over a patient with shorter anticipated survival | Saving the most | |
51.8 | A patient needing a small dose of a shortage drug should be prioritized over a patient needing a larger dose | Saving the most | |
57.2 | A patient using a drug for an approved indication should have priority over a patient using the drug for off-label use | Saving the most | |
61.0 | A patient who is starting therapy should be prioritized over a patient who has nearly completed therapy | Saving the most | |
74.3 | A patient using the shortage drug for curative intent should be prioritized over a patient using the drug for palliation | Saving the most | |
Strongly agree | 100.0 |
- Citation: Beck JC, Chen B, Gordon BG. Physician approaches to drug shortages: Results of a national survey of pediatric hematologist/oncologists. World J Clin Oncol 2017; 8(4): 336-342
- URL: https://www.wjgnet.com/2218-4333/full/v8/i4/336.htm
- DOI: https://dx.doi.org/10.5306/wjco.v8.i4.336